BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7314875)

  • 1. [Biochemical definition of uremia].
    Ringoir S
    Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875
    [No Abstract]   [Full Text] [Related]  

  • 2. A defense of the middle molecule hypothesis.
    Funck-Brentano JL; Cueille GF; Man NK
    Kidney Int Suppl; 1978 Jun; (8):S31-5. PubMed ID: 278894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
    Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA
    Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis of middle molecular substances in rat tissues: in vitro study.
    Dzúrik R; Cernácek P; Spustová V; Válek A
    Proc Eur Dial Transplant Assoc; 1978; 15():633-5. PubMed ID: 740703
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of toxic activity of blood in uremia].
    Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
    Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
    [No Abstract]   [Full Text] [Related]  

  • 6. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigations on clinico-chemical correlations in uraemic polyneuritis.
    Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum middle molecules in uremia.
    Buzio C; Manari A; Calderini C; Montagna G; Migone L
    Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract]   [Full Text] [Related]  

  • 9. Analytical study for separation of middle molecules.
    Saito A; Kanazawa I; Chung TG; Maeda K
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion-pair high-performance liquid chromatography profiling of a uremic toxin fraction.
    Gallice P; Monti JP; Le Gall JM; Crevat A; Murisasco A
    J Chromatogr; 1987 Nov; 422():263-6. PubMed ID: 3437013
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the significance of middle molecular retention products as uremia toxins].
    Goubeaud G; Leber HW; Schott HH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1244-6. PubMed ID: 611827
    [No Abstract]   [Full Text] [Related]  

  • 12. ["Middle molecules" as nonspecific regulators of phagocyte activity].
    Volchegorskiĭ IA; Vlasov AV; Livshits GE; Akhkiamov EM; Skobeleva NA; Lifshits RI; Ebert LIa
    Biull Eksp Biol Med; 1995 Feb; 119(2):159-62. PubMed ID: 7670039
    [No Abstract]   [Full Text] [Related]  

  • 13. What remains of the "middle molecule" hypothesis today?
    Brunner H; Mann H
    Contrib Nephrol; 1985; 44():14-39. PubMed ID: 3886282
    [No Abstract]   [Full Text] [Related]  

  • 14. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of blood toxicity in chronic uremia by an improved chromatographic method.
    Politi L; D'Angelo AR; Caramia M; Molinaro M; Nicoletti R; Cerulli N; Moriggi M; Scandurra R
    Clin Exp Dial Apheresis; 1981; 5(3):277-84. PubMed ID: 7333038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of determining middle molecules in the blood plasma in nephrological diseases].
    Gabriélian NI; Dmitriev AA; Kulakov GP; Melikian AM; Shcherbaneva OI
    Klin Med (Mosk); 1981 Oct; 59(10):38-42. PubMed ID: 7311409
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation].
    Buzio C; Dall'Aglio PP; Delmonte G; Montagna G; Migone L
    Minerva Nefrol; 1979; 26(1):45-8. PubMed ID: 471320
    [No Abstract]   [Full Text] [Related]  

  • 18. Middle molecules in hepatic coma and uremia.
    Chang TM; Lister C
    Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of small peptide in uremic serum by high-performance liquid chromatography.
    Mabuchi H; Nakahashi H
    J Chromatogr; 1982 Mar; 228():292-7. PubMed ID: 7076752
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of uremic peaks by high performance liquid chromatography and their behavior].
    Koide K; Toyama J; Inoue N; Koshikawa S; Akizawa T; Takahashi K; Hidaka S; Yamane Y; Nakao M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1101-10. PubMed ID: 3807043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.